Cure Kids Ventures — Full Portfolio
22 tracked investments · listed companies and verified rows first
Co-investorsArc AngelsIcehouse VenturesNZ Growth Capital Partners
Amaroq Therapeutics develops first-in-class therapies targeting long non-coding RNAs (lncRNAs) implicated in oncology and other diseases.
Biotech
Co-investorsBooster Innovation FundTenmileBrandon Capital Partners
Aroa Biosurgery develops soft tissue repair and wound management products based on its AROA ECM extracellular matrix platform, including bioscaffolds for acute and chronic wounds, surgical reconstruction, and hernia repair.
BiotechHealthtechMedical Devices
Co-investorsMovac
Avasa develops technology to simplify microsurgical procedures, replacing manual hand sewing with automated microvascular connection methods.
HardwareMedical Devices
Co-investorsBooster Innovation FundBridgewest VenturesMovacNZ Growth Capital Partners
BioOra develops and manufactures CAR-T cell therapies from New Zealand, targeting patients with cancer who currently lack access to these treatments in their local regions.
BiotechDigital HealthMedical DevicesNew Zealand, NZ
Co-investorsBooster Innovation FundBridgewest Ventures
Co-investorsBooster Innovation FundMatū
chnnl is an employee wellbeing platform that lets organisations gather feedback and trends from team members, encourage engagement with wellbeing resources, and report on psychological safety and the ROI of wellbeing investment.
HR TechMental HealthSaaS
Elizabeth Berryman(CEO & Founder)in
Formus Labs develops software for orthopaedic surgery, applying AI and algorithmic modeling to support surgical planning for hip and knee procedures.
AI & Machine LearningHealthtechMedical DevicesAuckland, NZ
Ju Zhang(Founder & CEO)inThor Besier(Co-founder & Chief Scientific Officer)inAntonije Velevski(Co-founder, former senior software engineer)inJustin Fernandez(Co-founder, Science Advisor)inSarah Wixon(Head of Finance)inMarco Schneider(Head of Product and Research)in
Co-investorsGD1Nuance CapitalNZ Growth Capital PartnersPacific ChannelPunakaiki Fund
Kitea Health is a medical device company spun out of the Auckland University Bioengineering Institute, developing the Kitea System, a microscale wireless sensor technology with applications in hydrocephalus and cerebrospinal fluid monitoring.
HardwareHealthtechMedical Devices
Simon Malpas(Director, Chief Executive Officer)inNatalia Jones(Director, Chief Operations Officer)inBryon Wright(Chief Technical Officer)in
Co-investorsAngel HQIcehouse VenturesPacific ChannelSoul CapitalElevate CapitalNZ Growth Capital Partners+1 more
Komodo Wellbeing publishes content on fostering a growth mindset and building resilience in students within the school environment.
EdTechMental HealthWellness & Fitness
Co-investorsBooster Innovation FundFlying Fox VenturesFolklore VenturesTiger Global Management
KERA99 is an online slot gambling platform offering 24/7 access to games from multiple providers with a mobile-responsive interface and customer support.
Gaming
MARS develops point-of-care photon counting CT imaging systems for community healthcare settings.
Deep TechHealthtechMedical DevicesChristchurch, NZ
Anthony Philip Howard Butler(Executive Officer, Director)Philip Howard Butler(Executive Officer, Director)Colin Ernest Dawson(Director)
Co-investorsBooster Innovation FundPacific Channel
NZeno develops porcine (pig) cell-based therapeutics and xenotransplantation technologies, building on work in encapsulated cell therapies and breeding pigs certified as tissue sources for human transplantation.
BiotechHealthtechMedical DevicesNew Zealand, NZ
Paul Tan(Founder Director & Chief Medical Officer)inOlga Garkavenko(Founder Director & Chief Scientific Officer)inBob Elliott(Founder & Director (Retired 2020))Peter Lai(Chief Executive Officer)
BoardHoward Moore(Chairman of the Board of Directors)in
Co-investorsNZ Growth Capital PartnersPacific Channel
Pictor Diagnostics develops a proteomics platform that enables researchers, diagnostics manufacturers, clinical labs, and veterinary clinics to perform multi-marker protein testing across diverse sample types.
BiotechDigital HealthMedical Devices
Jamie(CEO)in
Co-investorsNZ Growth Capital Partners
Syft develops SIFT-MS instruments that perform real-time, chromatography-free trace gas analysis of a broad range of volatile compounds, measuring multiple analytes such as benzene, formaldehyde, and hydrogen sulfide in a single run.
CleantechDeep TechHardware
Co-investorsAmpersand
The a2 Milk Company sells dairy products, including milk and infant formula, based on A2 protein.
ConsumerFoodTech
The Clinician builds a platform that captures and analyzes patient-reported outcomes and experiences (PROMs and PREMs) alongside clinical data to help health systems measure, benchmark, and improve care delivery.
Digital HealthHealthtechSaaSAuckland, NZ
The Insides Company develops medical devices for chyme reinfusion therapy, aimed at patients recovering from severe intestinal conditions such as inflammatory bowel disease, colorectal cancer, and intestinal fistulas.
HardwareHealthtechMedical Devices
Ian Bissett(Co-Founder & Chief Medical Officer)John(Co-founder & COO)Rob(Co-founder & CTO)Garth(CEO)
BoardDennis(Chairman)
Medical device company using laser verification to prevent injury and death from IV medication errors in hospitals.
Wellumio develops axana®, a portable, energy-efficient MRI system based on its Pulsed Gradient Free Mapping (PGFM) technology, designed to detect acute stroke quickly in front-line care settings.
AI & Machine LearningDeep TechHealthtechMedical Devices
Shieak Tzeng(Co-founder & Co-CEO)inSergei Obruchkov(Co-founder & Co-CEO)inGyan Barik(Executive Director, Business Operations & Australia)inZiad Rouag(General Manager USA)Harry Marfatia(Head of Finance)in
BoardSia Moussavi(Board Chairman)
Co-investorsBooster Innovation FundNuance CapitalOutset VenturesPacific ChannelIcehouse VenturesNZ Growth Capital Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.